303 studies found for:    Open Studies | "Urinary Bladder Diseases"
Show Display Options
Rank Status Study
21 Unknown  Investigation of the Suburothelial Myofibroblast Network and of Smooth Muscle Function and Control in the Human Urinary Outflow Tract
Condition: Incontinence, Overactive Bladder, Stress Urinary Incontinence
Intervention:
22 Recruiting Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract
Conditions: Urothelial Cancer;   Bladder Cancer;   Renal Pelvis Cancer;   Ureter Cancer;   Urethra Cancer
Interventions: Drug: Vinflunine;   Drug: Sorafenib
23 Recruiting A Study to Evaluate Tolerability and Patient Preference Between Myrbetriq® and Detrol® LA in Subjects With Overactive Bladder (OAB)
Condition: Overactive Bladder (OAB)
Interventions: Drug: Myrbetriq;   Drug: Detrol LA
24 Not yet recruiting Clasic Laryngeal Mask Airway(C-LMA) and I-gel Releated Regurgitation and Complications
Conditions: Bladder Tumour;   Prostate Hyperplasia
Interventions: Device: i-gel;   Device: C-LMA
25 Recruiting Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging
Condition: Bladder Cancer
Interventions: Procedure: Tissue Biopsy;   Procedure: Magnetic Resonance Imaging (MRI)
26 Recruiting A Double Blind Randomized Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis
Conditions: Hemorrhagic Cystitis;   Stem Cell Transplantation;   Decidual Stromal Cells
Interventions: Biological: Decidual stromal cells;   Biological: Placebo
27 Recruiting First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
Conditions: Transitional Cell Carcinoma;   Bladder Carcinoma;   Urothelial Carcinoma
Interventions: Drug: Everolimus;   Drug: Paclitaxel
28 Unknown  Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer
Condition: Bladder Cancer
Interventions: Biological: BCG solution;   Biological: recombinant interferon alfa;   Drug: epirubicin hydrochloride;   Drug: mitomycin C;   Other: laboratory biomarker analysis;   Procedure: hyperthermia treatment;   Procedure: quality-of-life assessment
29 Recruiting Microbiomes of Pelvic Pain
Conditions: Interstitial Cystitis;   Chronic Prostatitis;   Chronic Pelvic Pain Syndrome
Intervention:
30 Recruiting Perioperative Oral Nutrition Intervention for Patients Undergoing Radical Cystectomy
Condition: Bladder Cancer
Interventions: Dietary Supplement: Ensure Plus®;   Dietary Supplement: Multivitamin
31 Recruiting Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract
Conditions: Vesicoureteral Reflux;   Renal Hypodysplasia, Nonsyndromic, 1;   Chronic Kidney Disease
Interventions: Drug: nitrofurantoin;   Other: No prophylaxis;   Drug: Amoxicillin-Potassium Clavulanate Combination;   Drug: Trimethoprim/sulfamethoxazole;   Drug: Cefixime
32 Recruiting Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)
Conditions: Overactive Bladder;   Benign Prostatic Hyperplasia
Intervention: Drug: doxazosin plus tolterodine SR
33 Recruiting Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer
Conditions: Bladder Cancer;   Bladder (Urothelial, Transitional Cell) Cancer;   Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive);   Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy);   Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable
Interventions: Drug: Pazopanib (GW786034);   Drug: Paclitaxel
34 Recruiting A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy
Condition: Bladder Cancer
Interventions: Other: standard fluid management;   Other: fluid management guided by the EV1000
35 Recruiting A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Conditions: Transitional Cell Carcinoma of Bladder;   Urethra Cancer;   Ureter Cancer;   Malignant Tumor of Renal Pelvis
Interventions: Drug: Cisplatin;   Drug: Gemcitabine;   Biological: ALT-801
36 Recruiting Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography
Conditions: Breast Cancer;   Prostate Cancer;   Urinary Bladder Cancer
Intervention: Other: Injection of 64Cu-DOTA-AE105
37 Not yet recruiting Efficacy of Transcutaneous Nerve Stimulation on Improvement of Overactive Bladder Symptoms
Condition: Overactive Bladder
Intervention: Device: Sports TENS 2
38 Recruiting The Efficacy of Biomarker in Patient With Interstitial Cystitis/Painful Bladder Syndrome
Condition: Interstitial Cystitis
Intervention:
39 Recruiting An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder
Conditions: Urinary Incontinence;   Urinary Bladder, Overactive
Intervention: Biological: botulinum toxin Type A
40 Recruiting Clinical Efficacy of Changing the InterStim® Parameters in Patients With Interstitial Cystitis/Painful Bladder Syndrome
Conditions: Painful Bladder Syndrome;   Interstitial Cystitis;   Pelvic Floor; Insufficiency;   Bowel Dysfunction;   Sexual Dysfunction;   Pelvic Floor; Incompetency
Intervention: Other: Changing the Interstim parameter of '' Frequency" in patients with Interstitial Cystitis

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years